COVID-19: the endocrine opportunity in a pandemic
- 1 September 2020
- journal article
- review article
- Published by Edizioni Minerva Medica in Minerva Endocrinology
- Vol. 45 (3) , 204-227
Abstract
The 2019 Coronavirus disease (COVID-19) pandemic has disrupted the social, economical and medical system worldwide. Although it is strictly an infectious disease, its intricate bidirectional relationship with various non-communicable metabolic diseases and endocrinological factors has been observed. While diabetes, hypertension, obesity have been found to be independent risk factors for COVID-19 disease severity and mortality, more inclination towards sedentary lifestyle, psychosocial stress at this critical time may be the harbingers of metabolic syndrome. Thus, endocrinologists have a great opportunity to play their role to combat this pandemic. This paper examines how various endocrinological disorders influence the dynamics of COVID-19 and vice versa. Moreover, it also intends to review the clinical guidelines to be adopted in practice of endocrinology in this trying time.Keywords
This publication has 219 references indexed in Scilit:
- Glycolytic control of vacuolar-type ATPase activity: A mechanism to regulate influenza viral infectionVirology, 2013
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independentBiology of Sex Differences, 2010
- The sweeter side of ACE2: Physiological evidence for a role in diabetesMolecular and Cellular Endocrinology, 2009
- Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 DiabetesDiabetes Care, 2008
- Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteersAIDS, 2007
- Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumoniaClinical Chemistry and Laboratory Medicine (CCLM), 2007
- Age- and gender-related difference of ACE2 expression in rat lungLife Sciences, 2006
- Molecular mimicry of ACTH in SARS – implications for corticosteroid treatment and prophylaxisMedical Hypotheses, 2004
- Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosisThe Journal of Pediatrics, 1981